Hyal preclinical data

HYALF (Mississauga, Ontario) reported in vitro and in vivo studies that demonstrate the specific binding of hyaluronic acid (HA) to the intracellular adhesion molecule-1 ( ICAM-1).

Company-sponsored research in Sweden isolated ICAM-1 from liver and used antibodies to inhibit binding of HA, demonstrating saturable and specific binding, said HYALF President Samuel Asculai. The results were reported at the meeting of the Federation of European Connective Tissue Societies in Lyon. ...